Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2025-12-24 @ 10:08 PM
NCT ID:
NCT06332235
Eligibility Criteria:
Inclusion Criteria:
* Subject ≥ 20 years of age
* Newly diagnosed of acute brain injury with Foley insertion with 5 days
Exclusion Criteria:
* Subjects with already in use of α1A-adrenergic receptor blocker used
* Subjects with urethral trauma
* Subjects with a history of prostate, penile, testicular, bladder, or urethral cancer or has received pelvic radiation, systemic chemotherapy, or intravesical chemotherapy
* Expected survival days for brain injury less than 28 days
* Subjects with a history of renal dysfunction (elevated creatinine (\>2.0 mg/dL))
* Subjects with severe liver impairment (Child-Pugh score≧10)
* Subjects with CYP3A4 inhibitors (ketoconazole、clarithromycin、itraconazole、ritonavir) used
* Subjects with pregnancy
* Subject who has been in an investigational drug study in the past 3 months
* Subjects who is considered as ineligible for participation in this clinical study by the principle investigator or the co-investigator's judgement.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
100 Years
Study:
NCT06332235
Study Brief:
Protocol Section:
NCT06332235